NCT06004349View on ClinicalTrials.gov

Autoimmune and Autoinflammatory Genetics Study

RecruitingOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

April 5, 2032

Study Completion Date

April 5, 2032

Conditions

VEXAS SyndomeAutoinflammatory DiseaseAutoimmune DiseaseRheumatic Disease

Trial Locations (2)

10016

RECRUITING

NYC H+H/Bellevue, New York

RECRUITING

NYU Langone Health, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER